Lorazepam description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Lorazepam

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

LORAZEPAM DESCRIPTION


Lorazepam


CLINICAL PHARMACOLOGY






INDICATIONS & USAGE



LORAZEPAM CONTRAINDICATIONS




WARNINGS


PRECAUTIONS, Clinically Significant Drug Interactions)


Physical And Psychological Dependence





PRECAUTIONS









INFORMATION FOR PATIENTS


ESSENTIAL LABORATORY TESTS


CLINICALLY SIGNIFICANT DRUG INTERACTIONS







CARCINOGENESIS & MUTAGENESIS


PREGNANCY




NURSING MOTHERS



GERIATRIC USE

ADVERSE REACTIONS).
CLINICAL PHARMACOLOGY).
DOSAGE AND ADMINISTRATION).

LORAZEPAM ADVERSE REACTIONS





OVERDOSAGE


Symptoms

MANAGEMENT

The prescriber should be aware of a risk of seizure in association with flumazenil treatment, particularly in long-term benzodiazepine users and in cyclic antidepressant overdose.The complete flumazenil package insert includingCONTRAINDICATIONS,WARNINGS, andPRECAUTIONSshould be consulted prior to use.

DOSAGE & ADMINISTRATION







HOW SUPPLIED


240over0.5on one side andWATSONon the other side, supplied in bottles of 100, 500 and 1000.
1 mg: white, scored, round flat faced beveled edge, debossed with241over1on one side andWATSONon the other side, supplied in bottles of 100, 500 and 1000.
2 mg: white, scored, round flat faced beveled edge, debossed with242over2on one side andWATSONon the other side, supplied in bottles of 100, 500 and 1000.

STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Lorazepam




Lorazepam

Lorazepam

LORAZEPAM TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:52125-031(NDC:0591-0242)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
LORAZEPAM LORAZEPAM 2 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
LACTOSE
MAGNESIUM STEARATE
POLACRILIN POTASSIUM

Product Characteristics

Color Size Imprint Code Shape
white 7 mm 242;2;WATSON ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:52125-031-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA072926 2012-08-20


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.